Evidence map›Paper›PMID 37439685›Full record

ReviewClinical microbiology reviews2023

Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management.

George R Thompson, Jeffrey D Jenks, John W Baddley, James S Lewis, Matthias Egger, Ilan S Schwartz, Johannes Boyer, Thomas F Patterson, Sharon C-A Chen, Peter G Pappas and 1 more

Open access · greenAbstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 2 pooled it
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 2 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Infective Endocarditis byPathogens (Basel, Switzerland) · 2025
    Pooled it
  2. Brazilian guidelines for the diagnosis and treatment of candidemia and invasive candidiasis in adults and children.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Guideline
  3. Article
  4. Review
  5. Review
  6. Endocarditis Due toOpen forum infectious diseases · 2026
    Article
  7. Article
  8. Article
  9. Targeting multidrug-resistantMaterials today. Bio · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Synergistic eradication ofFrontiers in medicine · 2026
    Article
  15. Article
  16. Cardiovascular system characteristics in HIV/AIDS patients with talaromycosis.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 3 countries.

George R ThompsonDepartment of Internal Medicine, Division of Infectious Diseases, University of California-Davis Medical Center, Sacramento, California, USA.ORCID 0000-0001-8518-5750
Jeffrey D JenksDurham County Department of Public Health, Durham, North Carolina, USA.
John W BaddleyDepartment of Medicine, Division of Infectious Diseases, University of Maryland School of Medicine, Baltimore, Maryland, USA.
James S LewisDepartment of Pharmacy, Oregon Health & Science University, Portland, Oregon, USA.
Matthias EggerDivision of Infectious Diseases, ECMM Excellence Center for Medical Mycology, Department of Medicine, Medical University of Graz, Graz, Austria.
Ilan S SchwartzDivision of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina, USA.ORCID 0000-0002-7522-0281
Johannes BoyerDivision of Infectious Diseases, ECMM Excellence Center for Medical Mycology, Department of Medicine, Medical University of Graz, Graz, Austria.
Thomas F PattersonDepartment of Medicine, Division of Infectious Diseases, The University of Texas Health Science Center, San Antonio, Texas, USA.
Sharon C-A ChenCentre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Sydney, New South Wales, Australia.
Peter G PappasDepartment of Medicine Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Martin HoeniglDivision of Infectious Diseases, ECMM Excellence Center for Medical Mycology, Department of Medicine, Medical University of Graz, Graz, Austria.ORCID 0000-0002-1653-2824
Medical University of Graz · ATDuke University · USOregon Health & Science University · USThe University of Sydney · AUThe University of Texas Health Science Center at San Antonio · USUniversity of Alabama at Birmingham · USUniversity of California Davis Medical Center · USUniversity of Maryland, Baltimore · US

Funding

Virulence gene discovery in CoccidioidesU19AI166798 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Satya Dandekar · 2022 to 2026
$10.5M
NIAID NIH HHS U19 AI166798NIH HHS 5U19AI166798
6 · The paper itself

Abstract

Fungal endocarditis accounts for 1% to 3% of all infective endocarditis cases, is associated with high morbidity and mortality (>70%), and presents numerous challenges during clinical care.

Indexed as

CandidiasisEndocarditisEndocarditis, BacterialMycosesAntifungal AgentsAspergillusCandidaHumansAntifungal Agentscardiacdiagnosisendocarditisendocardiumfungalmycologicmycologytreatment

Identifiers

PMID37439685
PMCPMC10512793
OpenAlexW4384120032

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.